Get the Stockscreener App
1.97
5.74%
-0.12
After Hours:
1.96
-0.01
-0.51%
Evogene Ltd stock is traded at $1.97, with a volume of 228.27K.
It is down -5.74% in the last 24 hours and down -33.45% over the past month.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.
See More
Previous Close:
$2.09
Open:
$2.09
24h Volume:
228.27K
Relative Volume:
0.92
Market Cap:
$10.57M
Revenue:
$5.64M
Net Income/Loss:
$-23.88M
P/E Ratio:
-3.5818
EPS:
-0.55
Net Cash Flow:
$-22.36M
1W Performance:
-18.26%
1M Performance:
-33.45%
6M Performance:
-72.25%
1Y Performance:
-66.08%
1-Day Range:
$1.8901
$2.10
1-Week Range:
$1.8901
$2.8699
52-Week Range:
$1.8901
$10.40
Evogene Ltd Stock (EVGN) Company Profile
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-08-21 | Initiated | ROTH Capital | Buy |
| Jul-29-21 | Initiated | Aegis Capital | Buy |
| Dec-01-20 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-16-13 | Initiated | Oppenheimer | Outperform |
Evogene Ltd Stock (EVGN) Latest News
Evogene and Google Cloud Partner to Develop AI Foundation Model for Drug Discovery - HIT Consultant
Evogene stock hits 52-week low at $2.13 amid market challenges - Investing.com
Evogene partners with Google Cloud for AI-driven molecule design By Investing.com - Investing.com Australia
Evogene partners with Google Cloud for AI-driven molecule design - Investing.com India
Biomica to Present at Digestive Disease Week (DDW) Conference 20 - GuruFocus.com
Evogene announces collaboration with Google Cloud - MSN
Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design - StockTitan
Syngenta and Lavie Bio Announce Partnership to Discover and Deve - GuruFocus.com
Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya - Krishak Jagat English
Evogene Ltd. (NASDAQ:EVGN) Sees Significant Growth in Short Interest - MarketBeat
Evogene (NASDAQ:EVGN) Stock Crosses Below 200-Day Moving AverageShould You Sell? - MarketBeat
StockNews.com Begins Coverage on Evogene (NASDAQ:EVGN) - MarketBeat
Evogene stock hits 52-week low at $2.21 amid market challenges - Investing.com Nigeria
Evogene (NASDAQ:EVGN) Coverage Initiated by Analysts at StockNews.com - MarketBeat
Watershed, Evogene, and BGU to Expand Gene Editing Applications to White Leg Shrimp and Red Swamp Crayfish - ISAAA
Evogene (NASDAQ:EVGN) Shares Pass Below Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Evogene (NASDAQ:EVGN) Research Coverage Started at StockNews.com - MarketBeat
Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology - PR Newswire
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of ‘MicroFermentor’, a Unique Technology that Can Change the Economics of Ag-Biologicals - Krishak Jagat English
Lavie Bio receives grant to advance ag-biologicals tech - World Bio Market Insights
Evogene (NASDAQ:EVGN) Stock Price Crosses Below 200 Day Moving Average of $5.81 - MarketBeat
StockNews.com Initiates Coverage on Evogene (NASDAQ:EVGN) - MarketBeat
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals - Lelezard
Evogene receives grant from IIA to advance development of ‘MicroFermentor’ - TipRanks
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals – Company AnnouncementFT.com - Financial Times
Evogene stock hits 52-week low at $2.6 amid market challenges - Investing.com Canada
Casterra Announces Additional $2.2 Million of Purchase Orders to Supply Castor Seeds for New African Territories - GuruFocus.com
Biomica CEO Set to Attend JP Morgan Healthcare Week in San Franc - GuruFocus.com
Casterra Appoints New CEO and Expands Team to Drive Growth and I - GuruFocus.com
A Tale of Resilience: Evolv Technologies Holdings Inc Amid Stock Market Turbulence - The InvestChronicle
Evotec (NASDAQ:EVO) Sees Unusually-High Trading Volume - MarketBeat
Resolute Capital Asset Partners LLC Buys Shares of 200,000 Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) - Defense World
UBS slashes price target on EVgo Inc [EVGO] – find out why. - The DBT News
Biomica Successfully Completes Phase I Trial Enrollment for Micr - GuruFocus.com
328,106 Shares in Evolent Health, Inc. (NYSE:EVH) Acquired by Federated Hermes Inc. - Defense World
EVgo, Inc. Expected to Post Q3 2024 Earnings of ($0.11) Per Share (NYSE:EVGO) - Defense World
Evolus, Inc. (NASDAQ:EOLS) Shares Purchased by Arizona State Retirement System - Defense World
American Century Companies Inc. Reduces Holdings in Evolent Health, Inc. (NYSE:EVH) - Defense World
Arizona State Retirement System Has $78,000 Stock Holdings in Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) - Defense World
EVgo (NYSE:EVGO) Raised to Strong-Buy at Capital One Financial - Defense World
EVgo, Inc. Expected to Post FY2025 Earnings of ($0.39) Per Share (NYSE:EVGO) - Defense World
EVgo (NYSE:EVGO) Stock Price Down 6% - Defense World
Evolv Technologies Holdings, Inc. (NASDAQ:EVLVW) Sees Large Decline in Short Interest - Defense World
Evolus (NASDAQ:EOLS) Trading Down 2.9% - Defense World
Evolent Health, Inc. (NYSE:EVH) Short Interest Down 7.9% in August - MarketBeat
EVgo, Inc. (NYSE:EVGO) Expected to Earn FY2025 Earnings of ($0.39) Per Share - MarketBeat
EVgo stock price analysis: risk/reward is very attractive - Invezz
Evolv Technologies (NASDAQ:EVLV) Stock Price Up 3.1% - Defense World
Analytical Lens: Exploring Evolv Technologies Holdings Inc (EVLV)’s Financial Story Through Ratios - The Dwinnex
A better buy-in window may exist right now for Evolv Technologies Holdings Inc (EVLV) - SETE News
How did Evolus Inc (EOLS) fare last session? - US Post News
Evogene Ltd Stock (EVGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.02%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):